The mutation of LRP1B, typically associated with poor prognosis in other cancer types,9 also emerged as a significant indicator of poor survival in our cohort, underscoring the potential importance of this mutation in the early metastatic pathway of CRC. Here, LRP1B is linked to colorectal carcinoma.